Related Experiment Video
Updated: May 1, 2026

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
Published on: May 8, 2020
Lack of donor and recipient age interaction in cardiac transplantation
Farsad Alexander Eskandary1, Maria Kohl2, Daniela Dunkler2
1Department of Cardiac Surgery.
Insights
This study found no significant interaction between donor and recipient age impacting heart transplant outcomes. Independent risk factors like donor age and recipient age influence mortality and cardiac allograft vasculopathy (CAV).
Area of Science:
- Cardiology
- Transplantation Medicine
- Geriatric Medicine
Background:
- Increasing prevalence of older donors and recipients in heart transplantation (HTX).
- Limited understanding of the combined impact of donor and recipient age on HTX outcomes.
Purpose of the Study:
- To investigate the interaction between donor and recipient age on mortality and cardiac allograft vasculopathy (CAV) after HTX.
- To identify independent risk factors for adverse outcomes in HTX.
Main Methods:
- Retrospective cohort study of 1,190 HTX patients (1984-2011).
- Multivariable Cox models and competing risk models were used to analyze mortality and CAV.
- Adjustments were made for donor age, recipient age, transplant era, and other potential confounders/mediators.
Main Results:
- Donor age and recipient age were independent risk factors for mortality.
- Donor age and male recipient sex were significant risk factors for CAV.
- Recipient age showed an inverse association with CAV initiation; no significant interaction was found between donor and recipient age for death or CAV.
Conclusions:
- No significant interaction between donor and recipient age was observed to negatively affect mortality or CAV post-HTX.
- Identified independent risk factors, including donor and recipient age, have implications for organ allocation strategies, particularly for older recipients.
Background:
The proportion of older donors and recipients is constantly rising in heart transplantation (HTX). The impact of age on different outcomes after HTX has been studied; however, effects of interaction between donor and recipient age remain elusive.
Methods:
This retrospective cohort study comprised 1,190 patients who underwent HTX between 1984 and 2011 at the Medical University Vienna. Multivariable models consisted of a basic set that included donor age, recipient age, and transplant eras and were adjusted for 2 sets of 6 possible confounders and 3 mediator variables. Cox models were used to estimate the risk of death. To search for age-related effects on the development of cardiac allograft vasculopathy (CAV), we applied cause-specific Cox models and proportional sub-distribution hazard models for competing risk data.
Results:
Survival was 80%, 77%, 69%, and 56% after 1, 2, 5, and 10 years, respectively. Donor age (hazard ratio [HR], 1.1; 95% confidence interval [CI], 1.0-1.2), recipient age (HR, 1.1; 95% CI, 1.0-1.2), admission from intensive care unit to HTX (HR, 1.5; 95% CI, 1.2-1.9), and diabetes (HR, 1.4; 95% CI, 1.1-1.7) were identified as significant independent risk factors for death. Significant risk factors for CAV were donor age (HR, 1.4; 95% CI, 1.3-1.5) and male recipient sex (HR, 1.5; 95% CI, 1.0-2.2). Recipient age was inversely associated with initiation of CAV (HR, 0.8; 95% CI, 0.8-1.0). Analysis of the interaction between donor and recipient age was not significant for death (p = 0.8) or CAV (p = 0.6).
Conclusions:
We found no interaction between donor and recipient age negatively affecting mortality and CAV. The identified independent risk factors may have implications for allocation strategies in elderly recipients.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Cell-mediated Immune Responses

